+629.1%
MRNA vs FND
+48.9%
+580.2%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | FND | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.7% | -2.7% | -3.2% |
| 7D | -10.1% | -0.8% | -9.3% | -9.9% |
| 30D | +126.7% | -19.6% | +146.3% | +143.0% |
| 3M | +184.1% | -4.3% | +188.5% | +188.3% |
| 6M | +143.3% | -20.4% | +163.7% | +158.4% |
| YTD | +359.9% | -21.9% | +381.7% | +388.7% |
| 1Y | +454.2% | -45.2% | +499.4% | +546.3% |
| 3Y | +26.0% | -49.2% | +75.2% | +47.9% |
| 5Y | -70.3% | -61.8% | -8.4% | -65.6% |
| All | +629.1% | +48.9% | +580.2% | +793.1% |
Cumulative growth
Daily Returns
Daily percentage return beside FND.
Daily Out/Under-Performance
Portfolio return minus FND return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FND return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded FND wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling